Amicus Therapeutics
FOLD
#3908
Rank
$3.05 B
Marketcap
$9.90
Share price
-0.50%
Change (1 day)
1.43%
Change (1 year)

Amicus Therapeutics (FOLD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.63 Billion USD

According to Amicus Therapeutics 's latest financial reports the company's total liabilities are $0.63 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amicus Therapeutics - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.59 B-4.33%
2023-12-31$0.61 B2.76%
2022-12-31$0.60 B0.56%
2021-12-31$0.59 B-0.39%
2020-12-31$0.60 B60.56%
2019-12-31$0.37 B-16.39%
2018-12-31$0.44 B63.05%
2017-12-31$0.27 B-59.48%
2016-12-31$0.67 B20.72%
2015-12-31$0.56 B538.52%
2014-12-31$87.78 M7.31%
2013-12-31$81.81 M100.19%
2012-12-31$40.86 M1.65%
2011-12-31$40.2 M-15.57%
2010-12-31$47.61 M251.76%
2009-12-31$13.53 M-76.55%
2008-12-31$57.73 M-9.51%
2007-12-31$63.8 M-53.48%
2006-12-31$0.13 B112.65%
2005-12-31$64.49 M
2003-12-31$5.77 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
$11.00 B 1,623.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.55 B 144.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.81 B 27.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$61.28 B 9,499.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
$85.76 M-86.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$53.83 B 8,333.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark